Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Oct;18(4):598–603. doi: 10.1128/aac.18.4.598

Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.

W M Shannon, G Arnett, F M Schabel Jr, T W North, S S Cohen
PMCID: PMC284056  PMID: 6255863

Abstract

Although the antiviral activity of erythro-9-(2-hydroxy-3-nonyl)adenine, a potent adenosine deaminase inhibitor, against herpes simplex virus type 1 in cell culture was readily confirmed, the compound was found to be totally ineffective in the treatment of experimentally induced systemic herpes simplex virus type 1 infections in Swiss mice. Data were obtained, however, which clearly indicated that the antiviral potency of 9-beta-D-arabinofuranosyladenine in vivo could be enhanced by the co-administration of low, nontoxic doses of erythro-9-(2-hydroxy-3-nonyl)adenine.

Full text

PDF
598

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BABLANIAN R., EGGERS H. J., TAMM I. STUDIES ON THE MECHANISM OF POLIOVIRUS-INDUCED CELL DAMAGE. I. THE RELATION BETWEEN POLIOVIRUS,-INDUCED METABOLIC AND MORPHOLOGICAL ALTERATIONS IN CULTURED CELLS. Virology. 1965 May;26:100–113. doi: 10.1016/0042-6822(65)90030-9. [DOI] [PubMed] [Google Scholar]
  2. Bloch A., Robins M. J., McCarthy J. R., Jr The role of the 5'-hydroxyl group of adenosine in determining substrate specificity for adenosine deaminase. J Med Chem. 1967 Sep;10(5):908–912. doi: 10.1021/jm00317a034. [DOI] [PubMed] [Google Scholar]
  3. Bryson Y., Connor J. D., Sweetman L., Carey S., Stuckey M. A., Buchanan R. Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor. Antimicrob Agents Chemother. 1974 Jul;6(1):98–101. doi: 10.1128/aac.6.1.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cohen S. S. Introduction to the biochemistry of D-arabinosyl nucleosides. Prog Nucleic Acid Res Mol Biol. 1966;5:1–88. doi: 10.1016/s0079-6603(08)60231-7. [DOI] [PubMed] [Google Scholar]
  5. Doering A., Keller J., Cohen S. S. Some effects of D-arabinosyl nucleosides on polymer syntheses in mouse fibroblasts. Cancer Res. 1966 Dec;26(12):2444–2450. [PubMed] [Google Scholar]
  6. Ehrlich J., Sloan B. J., Miller F. A., Machamer H. E. Searching for antiviral materials from microbial fermentations. Ann N Y Acad Sci. 1965 Jul 30;130(1):5–16. doi: 10.1111/j.1749-6632.1965.tb12533.x. [DOI] [PubMed] [Google Scholar]
  7. Frederiksen S. Specificity of adenosine deaminase toward adenosine and 2'-deoxyadenosine analogues. Arch Biochem Biophys. 1966 Feb;113(2):383–388. doi: 10.1016/0003-9861(66)90202-5. [DOI] [PubMed] [Google Scholar]
  8. Johns D. G., Adamson R. H. Enhancement of the biological activity of cordycepin (3'-deoxyadenosine) by the adenosine deaminase inhibitor 2'-deoxycoformycin. Biochem Pharmacol. 1976 Jun 15;25(12):1441–1444. doi: 10.1016/0006-2952(76)90121-0. [DOI] [PubMed] [Google Scholar]
  9. Lapi L., Cohen S. S. Toxicities of adenosine and 2'-deoxyadrenosine in L cells treated with inhibitors of adenosine deaminase. Biochem Pharmacol. 1977 Jan 1;26(1):71–76. doi: 10.1016/0006-2952(77)90135-6. [DOI] [PubMed] [Google Scholar]
  10. LePage G. A., Worth L. S., Kimball A. P. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin. Cancer Res. 1976 Apr;36(4):1481–1485. [PubMed] [Google Scholar]
  11. North T. W., Cohen S. S. Aranucleosides and aranucleotides in viral chemotherapy. Pharmacol Ther. 1979;4(1):81–108. doi: 10.1016/0163-7258(79)90016-0. [DOI] [PubMed] [Google Scholar]
  12. North T. W., Cohen S. S. Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues. Proc Natl Acad Sci U S A. 1978 Oct;75(10):4684–4688. doi: 10.1073/pnas.75.10.4684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. PRIVATDEGARILHE M., DE RUDDER J. EFFET DE DEUX NUCL'EOSIDES DE L'ARABINOSE SUR LA MULTIPLICATION DES VIRUS DE L'HERP'ES ET DE LA VACCINE EN CULTURE CELLULAIRE. C R Hebd Seances Acad Sci. 1964 Oct 19;259:2725–2728. [PubMed] [Google Scholar]
  14. Plunkett W., Cohen S. S. Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase. Ann N Y Acad Sci. 1977 Mar 4;284:91–102. doi: 10.1111/j.1749-6632.1977.tb21939.x. [DOI] [PubMed] [Google Scholar]
  15. Plunkett W., Cohen S. S. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells. Cancer Res. 1975 Jun;35(6):1547–1554. [PubMed] [Google Scholar]
  16. ROTTMAN F., GUARINO A. J. STUDIES ON THE INHIBITION OF BACILLUS SUBTILIS GROWTH BY CORDYCEPIN. Biochim Biophys Acta. 1964 Apr 27;80:632–639. doi: 10.1016/0926-6550(64)90307-x. [DOI] [PubMed] [Google Scholar]
  17. Schabel F. M., Jr The antiviral activity of 9-beta-D-arabinofuranosyladenine (ARA-A). Chemotherapy. 1968;13(6):321–338. doi: 10.1159/000220567. [DOI] [PubMed] [Google Scholar]
  18. Schaeffer H. J., Schwender C. F. Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines. J Med Chem. 1974 Jan;17(1):6–8. doi: 10.1021/jm00247a002. [DOI] [PubMed] [Google Scholar]
  19. Schwartz P. M., Shipman C., Jr, Drach J. C. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor. Antimicrob Agents Chemother. 1976 Jul;10(1):64–74. doi: 10.1128/aac.10.1.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shannon W. M. Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo. Ann N Y Acad Sci. 1977 Mar 4;284:472–507. doi: 10.1111/j.1749-6632.1977.tb21983.x. [DOI] [PubMed] [Google Scholar]
  21. Shannon W. M., Westbrook L., Schabel F. M., Jr Antiviral activity of 9-beta-D-arabinofuranosyladenine (ara-A) against Gross murine leukemia virus in vitro. Proc Soc Exp Biol Med. 1974 Feb;145(2):542–545. doi: 10.3181/00379727-145-37848. [DOI] [PubMed] [Google Scholar]
  22. Sidwell R. W., Arnett G., Dixon G. J., Schabel F. M., Jr Purine analogs as potential anticytomegalovirus agents. Proc Soc Exp Biol Med. 1969 Sep;131(4):1223–1230. doi: 10.3181/00379727-131-34075. [DOI] [PubMed] [Google Scholar]
  23. Sloan B. J., Kielty J. K., Miller F. A. Effect of a novel adenosine deaminase inhibitor (co-vidarabine, co-V) upon the antiviral activity in vitro and in vivo of vidarabine (Vira-Atm) for DNA virus replication. Ann N Y Acad Sci. 1977 Mar 4;284:60–80. doi: 10.1111/j.1749-6632.1977.tb21937.x. [DOI] [PubMed] [Google Scholar]
  24. Whitley R. J., Ch'ien L. T., Dolin R., Galasso G. J., Alford C. A., Jr Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med. 1976 May 27;294(22):1193–1199. doi: 10.1056/NEJM197605272942201. [DOI] [PubMed] [Google Scholar]
  25. Whitley R. J., Soong S. J., Dolin R., Galasso G. J., Ch'ien L. T., Alford C. A. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11;297(6):289–294. doi: 10.1056/NEJM197708112970601. [DOI] [PubMed] [Google Scholar]
  26. York J. L., LePage G. A. A kinetic study of the deamination of some adenosine analogues. Substrate specificity of adenosine deaminase. Can J Biochem. 1966 Mar;44(3):331–337. doi: 10.1139/o66-039. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES